pETM30-C9ORF78_F8A
(Plasmid
#193369)
-
PurposeExpression of C9ORF78 F8A variant in E.coli with N-terminal His6-GST-tag which is cleavable with TEV protease
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 193369 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepETM30
-
Backbone manufacturerEMBL Heidelberg
- Backbone size w/o insert (bp) 6346
- Total vector size (bp) 6860
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Kanamycin, 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberLow Copy
Gene/Insert
-
Gene/Insert nameC9ORF78_F8A
-
SpeciesH. sapiens (human)
-
Insert Size (bp)870
-
MutationF8A, the mutation is located in the binding interface with SNRNP200
-
GenBank ID51759
-
Entrez GeneC9orf78 (a.k.a. CSU2, HCA59, HSPC220, TLS1, bA409K20.3)
- Promoter T7
-
Tag
/ Fusion Protein
- His6-GST-TEV (N terminal on backbone)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NcoI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer GEX5-for (Microsynth)
- 3′ sequencing primer T7term (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byC9ORF78 wild type was provided by the laboratory of Prof. Ulrich Stelzel, University of Graz (Austria) in a yeast expression vector.
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pETM30-C9ORF78_F8A was a gift from Markus Wahl (Addgene plasmid # 193369 ; http://n2t.net/addgene:193369 ; RRID:Addgene_193369) -
For your References section:
A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing. Bergfort A, Preussner M, Kuropka B, Ilik IA, Hilal T, Weber G, Freund C, Aktas T, Heyd F, Wahl MC. Nat Commun. 2022 Mar 3;13(1):1132. doi: 10.1038/s41467-022-28754-2. 10.1038/s41467-022-28754-2 PubMed 35241646